Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-28

FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)

View source ↗

Summary

FDA approved a supplemental application for olmesartan medoxomil filed by Quallent Pharmaceuticals Health LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

SUPPL AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)